(A) A managing pharmacist shall prescribe in accordance with a valid prescriber-patient relationship. This includes, but is not limited to, the following:
(1) Reviewing a thorough history of the patient;
(2) Conducting an initial consultation with the patient via in-person meeting, video conference or by telephone;
(3) Ordering tests and evaluation of test results in accordance with section 4729.39 of the Revised Code;
(4) Prescribing medication in accordance this division of the Administrative Code, ruling out the existence of any recognized contraindications;
(5) Consulting with the authorizing physician on the consult agreement when necessary; and
(6) Documenting these steps in the patient's medical record.
(B) The pharmacist's prescriptive authority shall not exceed what is specified in the consult agreement.
(C) A managing pharmacist shall comply with the same requirements of a physician pursuant to rules 4731-11-02, 4731-11-03, 4731-11-04, 4731-11- 04.1, 4731-11-08 and 4731-11-09 of the Administrative Code.
(D) A pharmacist, as part of an opioid treatment program licensed by the state, may administer controlled substance narcotics pursuant to a consult agreement in accordance with this division of the Administrative Code for the maintenance or detoxification treatment of opioid addiction.
(E) A managing pharmacist shall, at a minimum, conduct a follow-up consultation with the patient on an annual basis. The review shall be conducted via in-person meeting, video conference or by telephone and shall be documented in the patient's medical record.
(F) Paragraphs (A)(2) and (E) of this rule do not apply to the inpatient management a patient's drug therapy pursuant to a consult agreement in an institutional facility as defined in rule 4729-17-01 of the Administrative Code.